Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Life Sciences Industrial Strategy Is Starting To Show Its Value In The Medtech Arena

Executive Summary

UK strategies that have sought to maximize the partnership potential of medtech innovators and the country's National Health Service have often not lasted long enough to prove their worth. But Neil Mesher, Philips CEO of UK and Ireland, says the Life Sciences Industrial Strategy might just be different.


Related Content

UK Life-Sciences Sector Deal Brings Life And Funding To Industrial Strategy
Moonshot Projects In Life Sciences Strategy Can Lift UK Over Brexit Hurdle


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts